ARCHIVES

Guest Editorial: caBIG Has Another Fundamental Problem: It Relies On “Incoherent” Messaging Standard

This article is from The Cancer Letter archive.

Vol. 37 No. 16 | April 22, 2011

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI CTEP Last Month

July 29, 2011

FDA Staff Efforts To Issue Warning Letters On Procrit Ads Were Stopped By Counsel.

May 9, 2008

High Cervical Cancer Rates Indicate Access Problems

August 26, 2005

Administration’s FY 1981 Budget Would Leave Gaps, Curtail Many Program, Without New Cuts

March 28, 1980

FDA News: Zydelig approved in three B-cell blood cancers

August 1, 2014

Bill Introduced To Curb NIH Use Of Title 42 Salaries

August 10, 2012